Response Scientific Provides Unique New Approach in the Race to Develop Oral Insulin

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Diabetes is an epidemic. Nearly 26 million children and adults in the United States have diabetes, that's almost 10% of the entire population including 25% of all seniors. Over 79 million have prediabetes. It is expected that as many as 1 in 3 American adults will have diabetes by 2050 if present trends continue. The economic cost of diagnosed diabetes in America is over $245B per year.

For professionals on the front lines of the war on diabetes, finding easier ways to treat and support patients is critical. "Oral insulin has always been the 'most desirable' means for delivering insulin to diabetic patients," says Response Scientific's CEO, Gregg Webster. "The challenge is getting the insulin past the stomach where acids and enzymes destroy the insulin before reaching the bloodstream."

Although several leading companies have been working to overcome this particular problem, it seems that only Response Scientific has the current advantage of a new highly-advanced protective microencapsulation technology they are calling Microvail.™

http://www.globenewswire.com/news-r...oach-in-the-Race-to-Develop-Oral-Insulin.html
 
Status
Not open for further replies.
Back
Top